TRPV4 activation of endothelial nitric oxide synthase resists nonalcoholic fatty liver disease by blocking CYP2E1-mediated redox toxicity

NAFLD is a clinically progressive disease with steatosis, inflammation, endothelial dysfunction and fibrosis being the stages where clinical intervention becomes necessary. Lack of early biomarkers and absence of a FDA approved drug obstructs efforts for effective treatment. NAFLD progression is str...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Free Radic Biol Med
Glavni autori: Seth, Ratanesh K., Das, Suvarthi, Dattaroy, Diptadip, Chandrashekaran, Varun, Alhasson, Firas, Michelotti, Gregory, Nagarkatti, Mitzi, Nagarkatti, Prakash, Diehl, Anna Mae, Bell, P. Darwin, Liedtke, Wolfgang, Chatterjee, Saurabh
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5989309/
https://ncbi.nlm.nih.gov/pubmed/27913210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.freeradbiomed.2016.11.047
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items